Showing results (1861-1870 of 1,972) with videos related to

Sort By:
Pageof 198
Development (Cambridge, England)|June 12, 2014
Combinatorial actions of Tgfβ and Activin ligands promote oligodendrocyte development and CNS myelinationDipankar J Dutta, Andleeb Zameer, John N Mariani, et al.
Arthritis Research & Therapy|August 21, 2015
Treatment of systemic lupus erythematosus patients with the BAFF antagonist "peptibody" blisibimod (AMG 623/A-623): results from randomized, double-blind phase 1a and phase 1b trialsWilliam Stohl, Joan T Merrill, R John Looney, et al.
Heart, Lung & Circulation|July 7, 2015
Long Term Outcomes Following Freestyle Stentless Aortic Bioprosthesis Implantation: An Australian ExperienceAndrew G Sherrah, Richmond W Jeremy, Rajesh Puranik, et al.
The Spine Journal : Official Journal of the North American Spine Society|August 29, 2006
Assessment of injury to the posterior ligamentous complex in thoracolumbar spine traumaAlexander R Vaccaro, Joon Y Lee, Karl M Schweitzer, et al.
Scientific Reports|January 31, 2018
Investigating the origins of eastern Polynesians using genome-wide data from the Leeward Society IslesGeorgi Hudjashov, Phillip Endicott, Helen Post, et al.
The New England Journal of Medicine|October 24, 2008
K-ras mutations and benefit from cetuximab in advanced colorectal cancerChristos S Karapetis, Shirin Khambata-Ford, Derek J Jonker, et al.
Ambio|December 30, 2022
The impacts of a global pandemic on the efficacy and stability of contemporary wildlife conservation: South Africa as a case studyDavid A Ehlers Smith, Yvette C Ehlers Smith, Harriet T Davies-Mostert, et al.
Future Oncology (London, England)|September 28, 2023
ASPiRATION: Australian observational cohort study of comprehensive genomic profiling in metastatic lung cancer tissueAntony J Mersiades, Benjamin J Solomon, David M Thomas, et al.
The European Respiratory Journal|January 18, 2020
Early markers of cystic fibrosis structural lung disease: follow-up of the ACFBAL cohortNaomi E Wijker, Suzanna Vidmar, Keith Grimwood, et al.
Circulation. Heart Failure|June 12, 2013
A novel immunomodulator, FTY-720 reverses existing cardiac hypertrophy and fibrosis from pressure overload by targeting NFAT (nuclear factor of activated T-cells) signaling and periostinWei Liu, Min Zi, Hoyee Tsui, et al.
Pageof 198